What is the core of the Mediterranean diet?

It emphasizes fruits, vegetables, whole grains, legumes, nuts, seeds, olive oil, and fish, with limited red meat and processed foods.

Is the Mediterranean diet expensive?

It doesn't have to be. Focusing on seasonal produce and affordable protein sources like lentils and beans can make it budget-friendly.

How does the Mediterranean diet benefit heart health?

The diet's emphasis on healthy fats and antioxidants helps lower cholesterol and reduce inflammation.

Can men and women benefit equally from the Mediterranean diet?

Yes, but this study shows they may need different strategies to adhere to it successfully.

What are some simple ways to start incorporating the Mediterranean diet?

Start by swapping butter for olive oil, adding more vegetables to your meals, and eating fish twice a week.

What is a prior authorization, and why does it cause delays?

A prior authorization is a requirement from insurance companies that a healthcare provider obtain approval before prescribing a medication or device. This process can be time-consuming and create delays in access.

Why are 90-day prescriptions better than 30-day prescriptions for diabetes supplies?

Patients receiving 90-day supplies reported fewer access gaps, likely due to reduced administrative burdens and less frequent refill requests.

What can patients do if they experience a gap in their diabetes technology supplies?

Patients should contact their healthcare provider and supplier to explore options for expedited replacements or temporary solutions.

What is the role of insurance companies in addressing these access gaps?

Insurance companies can streamline the prior authorization process, cover supplies based on failure rates, and ensure timely processing of refill requests.

How common is device failure with CGMs and insulin pumps?

Device failure is a significant issue, with over 40% of CGM and insulin pump users reporting malfunctions frequently enough to disrupt their diabetes management.

Tag:

Diabetes mellitus

Health

GSNOR: A Novel Target for Treating Diabetic Vascular Disease

by Dr. Michael Lee – Health Editor October 2, 2025

written by Dr. Michael Lee – Health Editor

Targeting‌ S-Nitrosoglutathione Reductase Improves Vascular Function in Diabetic Rodent Models

Diabetic vascular complications represent a significant clinical challenge, often proving ⁣resistant to conventional glucose-lowering treatments.⁣ Recent research has identified S*-nitrosoglutathione reductase⁣ (GSNOR) as a key ‍contributor to⁣ these complications, presenting a novel therapeutic target. Utilizing unbiased proteomics, researchers discovered elevated GSNOR levels in the endothelial cells of patients with type⁤ 2 diabetes, and confirmed this‍ upregulation in both streptozotocin (STZ)-induced type 1 diabetes and *db/db type 2⁢ diabetes mouse models.

To investigate GSNOR’s role,the⁢ researchers genetically deleted Gsnor specifically in endothelial cells of STZ-induced type 1 diabetic mice. This ablation resulted in improved angiogenesis, preserved vascular permeability, and enhanced vasodilation. In vitro ‍studies further ⁢demonstrated ‌that GSNOR ‍deficiency protected endothelial cells from high glucose-induced dysfunction, evidenced by restored tube formation, increased spheroid sprouting, maintained barrier integrity, and reduced permeability.

Importantly, the mechanism driving these‍ effects ‍appears independent of GSNOR’s enzymatic activity. The study revealed that GSNOR directly binds to the transcription ⁣factor ⁤ETS-related gene (ERG), triggering its removal ⁤from ‌the nucleus ‍via‌ interaction ‍with chromosome region maintenance 1.

Based on these ⁤findings, the ⁣researchers developed NYY-001, ⁤an orally available compound ‍designed to‍ specifically ⁢disrupt the GSNOR-ERG interaction. Cryo-electron ⁤microscopy confirmed the direct binding of NYY-001 to GSNOR. ⁤ Treatment with NYY-001 in both STZ-induced type 1 diabetes and db/db ‍ type 2 ⁣diabetes mouse ‌models led to ‌enhanced postischemic neovascularization‍ and restoration of vascular ⁢permeability in peripheral vasculature.

These⁢ results establish‌ a critical mechanistic ⁣link between the GSNOR-ERG complex and ‌the advancement of diabetic vascular complications, ⁤and position NYY-001 as a promising therapeutic ⁣candidate for this challenging condition.

October 2, 2025 0 comments

Health

Raspberry Leaf Tea Lowers Blood Sugar Spikes

by Dr. Michael Lee – Health Editor September 3, 2025

written by Dr. Michael Lee – Health Editor

Raspberry Leaf Tea‘s Impact on Insulin Response to Sucrose: A⁣ New Study

A recent study published in ⁣ Nutrients (2025) by Alkhudaydi and Spencer investigated the effects ⁢of raspberry leaf tea on postprandial glucose and⁣ insulin responses in healthy adults. The research revealed a significant reduction in insulin surges following ‌the consumption of sucrose⁤ (table sugar) when paired wiht raspberry leaf‌ tea, but no such effect was observed with glucose alone.

The trial⁣ involved 22 participants, 20 of whom completed all study visits.Participants consumed either sucrose or glucose, with or without concurrent⁢ consumption of raspberry leaf tea⁢ brewed for five minutes – a readiness standardized to deliver ‌approximately 50 mg of total⁤ polyphenols, primarily ellagitannins and ellagic acid, ⁤per serving. blood samples were ⁤collected at baseline and at 15, 30, 60, 90, and 120-minute intervals post-consumption, with glucose analyzed using the hexokinase method and insulin via automated immunoassay.

Results demonstrated that when sucrose was consumed, raspberry leaf tea substantially lowered both glucose and insulin responses. Specifically, mean ⁢glucose levels decreased by 1.19 mmol/L ‌at 15 minutes (p = 0.001) and 2.03 mmol/L at 30 minutes (p = 0.0004). Insulin⁣ levels were suppressed by 113.9 pmol/L at ⁢15 minutes (p⁢ = 0.019),‍ 161.8 pmol/L at 30 minutes (p⁢ = 0.0008), and 139.4 pmol/L at 60 ‌minutes (p ⁤= 0.025).

Notably,no statistically significant differences in ⁤blood glucose or insulin were found between the tea and control conditions when participants ‍consumed glucose. Both glucose and insulin peaked at 30 minutes and returned to baseline levels by 120 minutes, nonetheless of tea intake.This finding indicates the beneficial effects of raspberry leaf tea are specific ⁢to ⁢disaccharide metabolism – the breakdown of sugars like sucrose -⁢ rather than monosaccharide absorption (like glucose).

The researchers hypothesize that the tea’s effect stems from its inhibition of carbohydrate-digesting enzymes, such as α-glucosidase and sucrase, likely due ⁢to the presence of ellagic acid and other polyphenols. Importantly, participants⁤ did not report any gastrointestinal side effects, suggesting raspberry leaf tea ‍could be a well-tolerated ‌dietary approach to managing glycemic responses.

The study acknowledges several limitations, including its acute design (single-dose), lack of blinding and placebo control, small and homogeneous‌ sample size, and short duration. These ‌factors limit the generalizability of the findings and preclude conclusions regarding long-term effects. The authors recommend larger, longer-term studies in more diverse populations, including individuals with impaired glucose ⁣control, to further investigate the potential of raspberry leaf tea as a natural modulator of postprandial glycemia.

September 3, 2025 0 comments

Health

Antibiotics and Autoimmune Disease Risk in Children: A National Study

by Dr. Michael Lee – Health Editor August 25, 2025

written by Dr. Michael Lee – Health Editor

Antibiotics in Pregnancy & Early Infancy: Minimal Autoimmune risk, But Caution Advised

A large, nationwide study in Korea investigated whether antibiotic use during pregnancy or early infancy ⁢is linked to an increased risk of autoimmune diseases in children. The findings offer reassurance: treating actual infections with antibiotics during these⁤ periods does not appear ‌to considerably raise the overall risk of autoimmune ‌conditions.

Researchers analyzed‍ data from⁤ a large cohort, carefully comparing children exposed to antibiotics⁣ for infections with unexposed siblings and using ⁢advanced statistical methods to account for potential‌ biases. Thay examined risks for a range of autoimmune diseases including type 1 diabetes, juvenile idiopathic arthritis, CrohnS disease, lupus, and autoimmune thyroiditis‌ (Hashimoto’s).Key findings⁤ include:

No overall increased risk: Antibiotic exposure during pregnancy and early‌ infancy was not associated with a higher risk of ⁢most autoimmune diseases.
Sibling studies support findings: Comparing siblings⁤ with differing antibiotic exposure reinforced the ⁢lack of association, controlling for shared genetics and habitat.
Subtle signals warrant further investigation: The study ⁤identified some potential, modest associations:
Crohn’s Disease: ‌ ⁤Exposure to broad-spectrum antibiotics (especially cephalosporins) ⁣during pregnancy, notably⁣ in the first or ⁣second trimester, and multiple prescriptions, showed a slight increase in risk.

Autoimmune Thyroiditis: A slightly‍ higher risk was observed in‍ male ⁣infants exposed very early in life (within the first two months).
Robust methodology: The study employed rigorous methods to ⁣minimize bias,focusing on children who had documented infections and controlling for confounding factors.

What this means for families and doctors:

The study suggests that antibiotics, when used appropriately to treat⁣ infections, are unlikely ⁤to increase⁢ a child’s ⁢long-term risk of ‍autoimmune disease. Though,clinicians should continue to prescribe antibiotics judiciously,considering the specific antibiotic ⁢class and timing,and remain vigilant for⁢ potential signals identified in the subgroup analyses. Further research is needed to confirm these subtle associations.

Source: choi, E.-Y., et al. (2025). Exposure to antibiotics during ‌pregnancy or early infancy and ‍the risk of autoimmune disease in children:⁣ A nationwide cohort study in Korea. PLoS Medicine. https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1004677

August 25, 2025 0 comments

Health

Mediterranean Diet: Gender Differences in Adherence and Lifestyle

by Dr. Michael Lee – Health Editor August 19, 2025

written by Dr. Michael Lee – Health Editor

Gender-Specific Strategies for Mediterranean Diet Success

Table of Contents

Gender-Specific Strategies for Mediterranean Diet Success

A groundbreaking study of over 4,000 adults has revealed that⁢ while both men and ⁣women benefit from adopting a mediterranean lifestyle, the pathways to success-and the specific health advantages-differ significantly between‌ the sexes. The research, published in ⁣ Frontiers in Nutrition, ⁣highlights the need for tailored approaches to nutrition and wellness programs.

Study Overview and Background

Researchers from an international team conducted an online survey ⁤across ten Mediterranean and neighboring countries during⁤ the summer of 2024.The study‌ focused ‍on ⁤adherence⁣ to the Mediterranean ‌Diet (MedDiet) and related lifestyle⁤ behaviors, utilizing⁤ the Mediterranean‍ lifestyle (MedLife) Index. Millions struggle with healthy eating despite understanding its impact on long-term health, with the meddiet consistently linked to reduced‍ risks of cardiovascular disease, type 2 diabetes, ‍and certain cancers (estruch ⁢et al., 2022). However, factors like globalization ⁣and access ‍to‌ affordable, healthy foods are eroding these conventional dietary patterns.

The‌ study assessed participants’‍ physical activity, sleep patterns, mental health, social engagement, and perceived barriers to ⁤adopting ‍a Mediterranean lifestyle.‍ dataómico

Key Findings: Divergent Paths to Wellness

While overall MedLife scores were comparable between men ⁣and women, the⁢ study uncovered ⁤distinct‍ patterns. Women demonstrated stronger⁤ adherence to core Mediterranean food choices, ⁤consuming ⁤less⁤ red and processed meat, utilizing olive oil and herbs more frequently, and⁣ prioritizing vegetable intake. Men, conversely, were ⁤more likely to meet recommended guidelines for fish, legumes, and moderate wine consumption.

Lifestyle behaviors also differed significantly. Men reported higher levels of physical activity, participation ⁣in team sports, and social interaction with friends. this correlated with better sleep ⁤efficiency and reduced ⁣sleep latency. Women, however, experienced longer sleep latency,‌ poorer sleep quality, and higher rates‌ of insomnia. ‍ Technology use was also more prevalent among ‌women.

Psychological well-being also‌ showed a gender gap. Women reported higher ‌levels ⁣of depression,⁤ anxiety, and stress, alongside⁢ a greater perceived need for psychosocial, physical, and⁣ nutritional support. Men were more likely to report‌ being symptom-free and not requiring additional support.

Did you ‍Know?

These psychological differences may⁤ stem‍ from a combination of biological factors and societal expectations.

Data Summary

ómico

Characteristic	Women	Men
Average Age	37.2 years	36.8 years
MedLife Score (Average)	Similar to Men
Red/Processed Meat Consumption	Lower
Physical Activity Level	Lower	Higher
Sleep Quality	Poorer	Better
Reported Stress Levels	Higher	Lower

The study ‍also revealed that higher MedLife scores were‍ positively correlated with increased physical activity, daily social participation, and sleep satisfaction, and negatively⁢ correlated ⁣with insomnia, stress, anxiety, and depression (p <‌ 0.001). This underscores the interconnectedness of diet and overall well-being.

Barriers to Adoption

Women reported facing more barriers to adopting the MedDiet, including attitudinal obstacles, knowledge gaps, and taste preferences. Men more frequently cited a⁢ lack⁤ of ⁤motivation and medical reasons. ⁢These barriers are likely influenced by ‍socioeconomic and cultural factors.

Pro Tip:

Addressing these gender-specific barriers is crucial for designing effective interventions.

Implications for Public Health

The findings suggest the need for gender-sensitive strategies to promote the Mediterranean lifestyle. For women, programs‍ could combine nutrition education with‍ sleep support and⁢ peer communities. For men, activity-focused initiatives, skills-based cooking classes, and hydration reminders-integrated with sports and social activities-may be more effective.⁣ These strategies should be culturally adapted to the specific regions.

Do you ‍think tailored nutrition programs are more effective than one-size-fits-all approaches? What challenges do you face when trying to adopt a ⁤healthier lifestyle?

Conclusions

This large-scale study confirms the benefits of the Mediterranean lifestyle for both men ‌and women,but emphasizes ⁤that the pathways to achieving those benefits are ⁣distinct. By acknowledging these differences and tailoring interventions accordingly, public health efforts can maximize⁢ impact and promote equitable health outcomes. Further longitudinal research is needed to establish causality and refine these recommendations.

The Mediterranean diet‍ has been consistently recognized as‌ one of the healthiest dietary patterns globally. its emphasis on ⁢whole, unprocessed foods,⁤ healthy fats, and social connection aligns with current nutritional guidelines and promotes long-term well-being. The growing prevalence of ultra-processed foods and sedentary lifestyles underscores the importance of promoting lasting ⁢dietary changes. Future research will likely focus on the specific mechanisms by which the MedDietómico

Frequently ‌Asked Questions about the Mediterranean diet

what is the core ⁤of the ⁢Mediterranean diet? It emphasizes fruits, vegetables, whole grains, legumes, nuts, seeds, olive oil, and fish, with limited red meat and processed foods.
Is the Mediterranean diet expensive? It doesn’t have to be.‌ Focusing on seasonal produce and affordable protein sources like lentils and beans can make it budget-friendly.
How does the Mediterranean diet‌ benefit heart health? The diet’s emphasis on healthy fats and antioxidants helps lower cholesterol and reduce‌ inflammation.
Can men and⁢ women benefit equally from the Mediterranean diet? ⁣Yes, but this study shows they may need different strategies to ‍adhere to it successfully.
What are some simple ways to start incorporating the Mediterranean diet? Start by swapping butter for olive oil, adding more vegetables‍ to your meals, and eating fish twice a week.

We hope this article has provided valuable insights into the gender-specific aspects of ⁢the ‍Mediterranean diet.Please share this information ⁤with your friends and family, and let‍ us know your thoughts in the commentsómico

August 19, 2025 0 comments

Health

Diabetes Supply Gaps: Device Failures and Access Challenges Persist

by Dr. Michael Lee – Health Editor August 17, 2025

written by Dr. Michael Lee – Health Editor

Diabetes Technology Access:‌ Supply Disruptions Linked ⁤to Poorer Health outcomes

Table of Contents

Diabetes Technology Access:‌ Supply Disruptions Linked ⁤to Poorer Health outcomes

Virginia Beach,VA – A recent study highlights widespread challenges patients face in consistently accessing essential diabetes technology,leading ‍to disruptions⁢ in care and⁣ perhaps worsening health. The findings, presented at the American Diabetes Association’s 85th ‌Scientific Sessions, underscore a‌ critical need for systemic improvements in supply chains and‌ insurance coverage.

Key Findings on Diabetes Technology⁤ Access

Researchers found⁤ that⁤ interruptions in obtaining prescribed supplies-including continuous glucose monitors (CGM), insulin pumps, and insulin itself-are surprisingly common. These gaps stem from a complex interplay of factors, primarily insurer requirements,⁤ supplier delays, ⁢and prescription renewal issues.⁤ ⁣According to the study, 42.7% of ⁢CGM ‌users and 27.3% of insulin pump users experienced at least one supply gap⁣ annually, while 12.7% reported interruptions‌ in insulin access.

“Almost every single day‌ this theme comes up‍ with⁤ patients where they have prescribed diabetes technology supplies,⁤ but something happens to interrupt that supply and they’re not able to use ⁢the system as intended,” explained Dr. Andrew Welch, ‌an⁤ endocrinologist at the University of Cincinnati College of⁢ Medicine.⁣

Factors ⁢Contributing to Supply Gaps

The study pinpointed three primary drivers of these access problems: prior ‌authorization demands from insurance companies, processing delays at supplier ⁤facilities, and‍ delays‌ in receiving updated prescriptions from physicians. These hurdles disproportionately affect‌ individuals with lower incomes and those enrolled in Medicaid.

Did You Know?

Patients receiving 30-day prescriptions for ‍supplies experienced significantly ⁢more access gaps compared to those with 90-day prescriptions.

Early⁤ device failure⁤ also plays a ample role. The research⁢ revealed⁤ that 42% of CGM users and 47% of insulin pump users reported experiencing device malfunctions frequently enough-more than 10% of the time-to disrupt their diabetes management. Failure rates varied by brand, ranging from 39% with the Dexcom G6 to 53% ⁢for Abbott’s FreeStyle Libre 3 for ⁣CGMs, and from 34% with⁢ Medtronic’s MiniMed 780G to 53% for Insulet’s Omnipod 5 for insulin⁣ pumps.

Impact ⁣on Patient Health and Socioeconomic Status

Access⁢ gaps were ‌demonstrably linked to poorer glycemic control, as measured by A1C levels.⁢ Individuals with A1C levels above 7.0% reported significantly‍ more frequent supply‌ interruptions. ‍ This correlation highlights⁢ the critical importance of uninterrupted access to technology for effective diabetes management. According to the ⁢Centers for disease Control and Prevention, maintaining⁣ an A1C below 7.0% is a key goal for ⁢many‍ individuals‍ with diabetes [[CDC]].

Dr. ⁣David T. ⁢Ahn, chief of diabetes services at Hoag Memorial Hospital Presbyterian, noted the findings weren’t entirely ⁢surprising. “There’s a⁢ group of‍ people who don’t report any problems with ⁣this, and then there’s a group who‌ has so many problems that it can take over the whole ⁢clinical picture ⁤of that⁣ person’s diabetes care,” he stated.

Data Summary: Diabetes Technology ‍Access Gaps

Technology	Percentage Reporting Any Gap Per Year	Average Number of⁢ Gaps Per Year
Continuous Glucose Monitor (CGM)	42.7%	2.6
Insulin Pump	27.3%	2.4
insulin	12.7%	2.2

Pro‌ Tip:

Patients⁣ can proactively mitigate potential gaps by discussing longer prescription durations (e.g., 90-day supplies)⁣ with their healthcare providers.

Potential Solutions and Calls for Change

Researchers ‍and ⁤clinicians ⁤are advocating for systemic changes to address these challenges. Dr. Welch emphasized ‌the ⁤need for insurance companies to cover diabetes supplies based on documented failure rates and physician-prescribed quantities, without imposing burdensome prior authorization requirements. He suggested that insurers should cover quantities‍ of supplies based on published failure rate data or ‍physician-prescribed ⁢amounts, streamlining ‌the process for ⁣patients.

Some workarounds, such as providing free samples or prescribing larger⁤ quantities of supplies, have⁣ limited effectiveness, particularly with items like CGM sensors, which⁣ have ‌fixed usage durations. ‍ Optimizing workflow within practices,⁣ especially those specializing‍ in type‍ 1 diabetes management, is also‍ crucial, according to Dr. Ahn.

What steps ‍can⁢ be taken to ensure equitable‌ access to diabetes technology for all patients? How can healthcare providers and insurance companies collaborate to streamline the supply chain‍ and reduce administrative burdens?

The Growing Landscape of Diabetes⁣ Technology

The prevalence of diabetes ⁤continues to rise globally, with an estimated 537 ⁣million adults living with⁣ the⁣ condition in 2021 [[IDF]]. Advances in diabetes technology, such as ⁣CGMs and ⁤insulin pumps, have revolutionized diabetes management,⁢ offering improved glycemic control and quality of life. Though, these ⁤technologies ⁤are only effective when patients have‌ consistent access to⁣ them. The ongoing challenges highlighted in this research underscore the need for continued advocacy and innovation to ensure that all individuals with diabetes ‌can benefit from these life-changing tools.

Frequently ⁣Asked Questions‌ About Diabetes Technology Access

What is ⁤a prior authorization,‍ and why dose it⁢ cause delays? A prior ‍authorization is a requirement from insurance‌ companies that a⁢ healthcare provider obtain approval before prescribing a medication or device. This process can be time-consuming and‌ create delays in access.
Why ‌are 90-day prescriptions better than 30-day prescriptions for diabetes supplies? Patients receiving ⁣90-day supplies reported⁣ fewer access gaps,likely due to reduced administrative‌ burdens and less frequent refill requests.
What can patients do ⁢if they experiance ‍a gap in their ‍diabetes technology supplies? Patients should contact their healthcare⁤ provider⁣ and supplier to explore options for expedited replacements or⁣ temporary solutions.
What is the role of insurance companies in addressing these access gaps? Insurance companies can streamline the prior authorization process, cover supplies based on failure rates, and‍ ensure timely processing of refill requests.
How common⁢ is device ⁣failure ⁤with CGMs ⁣and insulin ⁢pumps? Device failure is a significant issue, with over 40% of ⁤CGM and insulin pump users ⁢reporting malfunctions frequently enough to disrupt their diabetes management.

Disclaimer: This article⁢ provides general data⁣ and should not be considered medical advice. Please consult with a qualified healthcare professional ⁣for personalized guidance on diabetes management.

We hope this article sheds light on the ⁢critical‍ issue of diabetes technology ‌access. please share this information with your ⁣network to raise awareness and advocate for improved care for individuals living with diabetes. Your comments and feedback are always ‍welcome!

August 17, 2025 0 comments

Health

Insulin Advancements Led to Safer Surgeries, Shorter Hospital Stays

by Dr. Michael Lee – Health Editor July 11, 2025

written by Dr. Michael Lee – Health Editor

Diabetes Management During Surgery Evolves

Personalized Approaches Key to Improved Outcomes

Surgical procedures for individuals with diabetes demand careful, tailored approaches, particularly concerning insulin regimens. Recent findings underscore the importance of customized care, with pharmacy teams playing a crucial role in pre-operative assessments to mitigate medication errors and optimize patient safety.

Advancements in Insulin Therapies

Novel insulins and technology have significantly improved diabetes management during the perioperative period, according to research in the British Journal of Anaesthesia. “Although the prevalence of diabetes is ∼10% in the community, it is ∼25% in the inpatient and surgical patients,” the authors wrote, emphasizing the need for optimized glycemic control to prevent chronic complications.

Diabetes-Related Hospitalizations on the Rise

Hospitalizations related to diabetes saw an increase between 2010 and 2019, climbing from 3079 to 3280.8 per 100,000 patients, according to the Journal of Clinical Medicine. Researchers attribute this rise to the simultaneous increase in diabetes cases, with the CDC reporting that 38.4 million people in the U.S. have diabetes.

Researchers assessed which insulin regimens would be the most effective for patients with diabetes undergoing surgery. | image credit: miss irine / stock.adobe.com

Pharmacological and Non-Pharmacological Options

Various therapeutic options are available to mitigate diabetes complications, broadly categorized as pharmacological and non-pharmacological. These include rapid-acting insulin analogues, regular soluble human insulin, intermediate-acting insulin, long-acting insulin analogues, and ultralong-acting insulin analogues.

Challenges in Perioperative Settings

Despite advancements in diabetes management, surgery on individuals with diabetes carries a mortality risk ranging from 3.7% to 13.2%. Current insulin methods being explored perioperatively include glucose–insulin–potassium regimen, variable rate intravenous insulin infusion (VRIII), basal-only insulin, and basal-bolus insulin.

The Role of Pharmacy Teams

According to the study authors, “The management of diabetes during the perioperative period should begin as soon as the decision to proceed with a surgical procedure is made.” Pharmacy teams play a vital role in ensuring safe medication administration during this period, particularly in pre-assessment clinics.

Personalized Approach is Essential

Prior to operations, pharmacists must understand the appropriate insulin regimens to best accommodate patients, since individuals with diabetes undergoing surgery require a highly personalized approach. The American Diabetes Association recommends regular monitoring and adjustments to treatment plans to manage blood sugar levels effectively, especially before, during, and after surgery (ADA, 2024).

Future Developments

“This review has discussed the current state of the safe use of insulin medicines during surgery and critical care admission; however, it is expected that further medications and drug delivery systems will be developed, and thus strategies will continue to evolve,” the authors concluded, noting the importance of maintaining safe glucose concentrations and preventing adverse drug events.

July 11, 2025 0 comments

Newer Posts

Older Posts

Diabetes mellitus

Targeting‌ S-Nitrosoglutathione Reductase Improves Vascular Function in Diabetic Rodent Models

Raspberry Leaf Tea‘s Impact on Insulin Response to Sucrose: A⁣ New Study

Antibiotics in Pregnancy & Early Infancy: Minimal Autoimmune risk, But Caution Advised

Gender-Specific Strategies for Mediterranean Diet Success

Study Overview and Background

Key Findings: Divergent Paths to Wellness

Data Summary

Barriers to Adoption

Implications for Public Health

Conclusions

Frequently ‌Asked Questions about the Mediterranean diet

Diabetes Technology Access:‌ Supply Disruptions Linked ⁤to Poorer Health outcomes

Key Findings on Diabetes Technology⁤ Access

Factors ⁢Contributing to Supply Gaps

Impact ⁣on ​Patient Health and Socioeconomic Status

Data Summary: Diabetes Technology ‍Access Gaps

Potential Solutions and Calls for Change

The Growing Landscape of Diabetes⁣ Technology

Frequently ⁣Asked Questions‌ About Diabetes Technology Access

Diabetes Management During Surgery Evolves

Personalized Approaches Key to Improved Outcomes

Advancements in Insulin Therapies

Diabetes-Related Hospitalizations on the Rise

Pharmacological and Non-Pharmacological Options

Challenges in Perioperative Settings

The Role of Pharmacy Teams

Personalized Approach is Essential

Future Developments

Impact ⁣on Patient Health and Socioeconomic Status